VacciTalks: Behind the Scenes: Challenging Race of Vaccine Development

Welcome to VacciTalks by Alira Health – exclusive educational appointments with the leading vaccine experts.

Multimedia
Category:
Published on:
May 10, 2022

For private companies, vaccine development is difficult, risky and takes time and money. Only a few candidates will reach the market and will help to protect patients. Companies are in severe competition to develop and bring their final vaccine products into the supply chain. In the second episode of VacciTalks, together with vaccine expert Roberto Camerini we peeked behind the scenes of vaccine development and get a unique insider look at vaccine development. We discussed difficulties, hurdles, and bottlenecks that vaccine produces face during the vaccine development and even after the product is delivered to the market and ways to overcome them.

During this VacciTalk you can learn:

  • How to set up a pipeline for a vaccine candidate
  • How to navigate process difficulties and prevent bottlenecks
  • Why partners, support, collaboration, and funding are essential
  • Market outlook and prospects for newly developed vaccines

In the course of his career, Roberto has held important management roles in Research and Development for international pharmaceutical groups (Abbott, Serono, Sigma-tau, Alfa-Wassermann, Alfasigma, Cosmo) where he was involved in the development and registration of new molecules and biological products in different therapeutic areas.

He served as Board Director of Sciclone Pharmaceutical Inc. and he is also co-founder and member of the board of directors of the Nibit Foundation (Italian Network for the Biotherapy of Tumors).

Roberto graduated cum laude in Medicine and Surgery at University of Rome “La Sapienza” and specialized with full marks in Liver and Metabolic Diseases at the same University.

Roberto is currently the Medical Director of ReiThera Srl.

Our hosts 

Bernd Schollmeier, Vice President, Global Market Access Vaccines 
Bernd Schollmeier

A vaccine expert with more than 30 years of experience, Bernd has been responsible for a range of global pricing and market access initiatives for vaccines in the international pharmaceutical companies — from delivering a range of solutions across development and strategic market access considerations for trial design to value demonstration in P&R negotiations as well as commercialization strategies.

 

Kenny Carberry, Associate Director, Clinical Development 
Kenny Carberry

Kenny’s background covers a wide array of indications across pharma, medical devices, and digital health. He has multiple years of experience in clinical trial operations and management and offers a unique perspective on the clinical development lifecycle from generating a comprehensive strategy through executing a successful trial.

 

About VacciTalks

VacciTalks is a series of unique appointments with the Key Opinion Leaders of the vaccine world. During each of the episodes, our hosts Bernd Schollmeier and Kenny Carberry will sit down with their guests and talk about the topics that disrupt the vaccine world right now – from development challenges to COVID-19 impact, new technologies, and much more.  

Follow us on LinkedIn and never miss the next VacciTalk!  

Related news

Events January 27, 2023
Alira Health and Biocat Startup Support Program Presentation
Biocat and Alira Health partnered to foster Market Access for startups. Alira Health, a global healthcare advisory and technology company, and Biocat, a strategic stakeholder building(...)
Market Access Startups
Publications January 20, 2023
Insights on Market Access
To get her perspective on market access and what to expect in 2023, we spoke with Nerea Blanqué, Senior Vice President of Market Access and Pricing at Alira Health.
Market Access Medical Devices Pharma
Publications December 21, 2022
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
Clinical Digital Health Market Access MedTech Pharma Regulatory
News November 15, 2022
Alira Health Partners with Policy Matters to Foster Market Access in the UK
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist(...)
Digital Health Healthcare Consulting Market Access
News November 10, 2022
Alira Health and GDMH together to boost Life Sciences innovation
The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.
Clinical Trials Digital Health DTx Market Access Real-World Evidence RWE
Events October 7, 2022
Debate Sobre los IPT en Oncología
We are pleased to announce our next event, “Debate Sobre los IPT en Oncología,” focusing on price and reimbursement (P&R) of vital oncology and oncohematology therapies.
Market Access Product Development Regulatory
Publications October 5, 2022
Relative Weight of the Variables Evaluated Through the Therapeutic Positioning Reports in the Pricing and Reimbursement of Oncological and Oncohematology Medicines in Spain
Discover how companies’ target prices are impacted by the different variables leveraged during the P&R process for oncology and oncohematology’s first indication.
Market Access Oncology Spain
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.